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Background: The purpose of this study was to evaluate the utility of a noninvasive ultrasound-based method,
vibro-acoustography (VA), for thyroid imaging and determine the feasibility and challenges of VA in detecting
nodules in thyroid.
Methods: Our study included two parts. First, in an in vitro study, experiments were conducted on a number of
excised thyroid specimens randomly taken from autopsy. Three types of images were acquired from most of the
specimens: X-ray, B-mode ultrasound, and vibro-acoustography. The second and main part of the study includes
results from performing VA and B-mode ultrasound imaging on 24 human subjects with thyroid nodules. The
results were evaluated and compared qualitatively.
Results: In vitro vibro-acoustography images displayed soft tissue structures, microcalcifications, cysts and nodules
with high contrast and no speckle. In this group, all of US proven nodules and all of X-ray proven calcifications of
thyroid tissues were detected by VA. In vivo results showed 100% of US proven calcifications and 91% of the US
detected nodules were identified by VA, however, some artifacts were present in some cases.
Conclusions: In vitro and in vivo VA images show promising results for delineating the detailed structure of the
thyroid, finding nodules and in particular calcifications with greater clarity compare to US. Our findings suggest
that, with further development, VA may be a suitable imaging modality for clinical thyroid imaging.
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ImagingBackground
The clinical practice of thyroidology has been revolution-
ized over the last decade by the inclusion of real-time
ultrasound (US) in the evaluation of nodular thyroid dis-
ease. Ultrasonography can accurately determine the
number and the size of thyroid nodules. US imaging is
extremely useful in guiding fine needle aspiration biopsy
(FNAB); however, its role in predicting malignancy is
limited such that ultrasound-guided FNAB is carried out
routinely in the evaluation of thyroid nodules [1]. Con-
ventional ultrasound characteristics of thyroid nodules
are not sufficiently specific to reliably determine the ma-
lignant potential of thyroid nodules [2]. Thus, despite the
obvious utility of conventional ultrasound, the gold* Correspondence: Alizad.azra@mayo.edu
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reproduction in any medium, provided the orstandard for diagnosis of benign versus malignant thy-
roid nodules is the FNAB [2,3].
FNAB is an invasive procedure and technique accuracy
depends largely on the skill of the aspirator, the expertise
of the cytologist, and the difficulty in distinguishing some
benign cellular adenomas from their malignant counter-
parts and wide variability in interpretative skill regarding
cytopathology of the thyroid nodule. Because of these
limitations, the results are indeterminate in approxi-
mately 15-20% of cases. Analysis of recent data from
some series suggests a false-negative rate of up to 11%, a
false-positive rate of up to 8%, with a sensitivity of about
80%, and a specificity of 73% [4-8].
Thyroid magnetic resonance imaging (MRI) and X-ray
computed tomography (CT) scans are not as sensitive as
US in detecting thyroid nodules, however, they are help-
ful in staging of the thyroid cancer [9,10].
Another major area of uncertainty in the management
of thyroid nodules is the issue of follicular neoplasm oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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follicular neoplasm, most of which are benign follicular
adenomas, but 10-20% are follicular thyroid cancers.
Neither conventional ultrasound appearance nor FNAB
is sufficient to distinguish between these two lesions
largely because the cytology of follicular adenoma is not
sufficiently different from that of follicular carcinomas
[3,11,12]. Currently, most of patients with FNAB cy-
tology indicating “follicular neoplasm” or “suspicious for
follicular neoplasm” are sent for thyroidectomy in order
to make a definitive diagnosis. Thus, this issue repre-
sents a major area of clinical practice that requires new
and innovative technological approaches for resolution.
Improved methods for thyroid nodule differentiation
are required to effectively and appropriately select biopsy
candidates in suspected nodules within the thyroid. Elas-
ticity imaging is an emerging field of medical imaging
for noninvasive and objective evaluation of tissue visco-
elasticity. Magnetic resonance elastography (MRE) can
be used to differentiate normal and pathological thyroid
gland [13], however, this method is based on expensive
MRI technology and thus less likely to see wide clinical
application. Thyroid static ultrasound elastography has
been developed to obtain tissue stiffness information
[14,15]. The resulting image is typically the strain distri-
bution after a stress has been applied by the user which
reflects the elastic characteristics of tissues. There are
very promising reports in clinical applications in thyroid
nodules [16-22]. However, it has not been proven that
real-time elastography alone is useful in differentiation
of thyroid nodules and the technique needs additional
quantitative information [23].
Acoustic radiation force impulse (ARFI) imaging and
supersonic imaging (SSI) use ultrasound radiation force
to generate shear waves and quantify tissue elasticity
from measured propagation speed of shear wave. Studies
using ARFI and SSI for thyroid nodule screening provide
quantitative tissue elasticity information and preliminary
results have been very promising [24-31]. However, the
sensitivity of SSI and ARFI in differentiation of thyroid
nodules is not high as a stand-alone diagnostic tool [32].
Thus, the role of imaging in thyroid cancer detection
continues to evolve. In this paper, we present the in vitro
and in vivo results of an imaging modality called vibro-
acoustography on human thyroid.
Vibro-acoustography (VA) is a methodology based on
the dynamic radiation force of ultrasound [33,34]. In this
technique, the ultrasound energy is converted into a
low-frequency vibration, which in turn produces a sound
that is used to construct the image. Hence, a VA image
is sensitive not only to the ultrasound properties of the
object but also to the dynamic behavior of the object at
low frequencies, which means that VA offers informa-
tion that is not available with conventional ultrasound.We researched and evaluated the use of VA for thyroid
imaging. In particular, we focused on studying images of
the tissue structures and various lesions in excised thy-
roid samples as well as human thyroid in vivo. The goal
of this study was to understand the properties of thyroid
images and to pave the way for a larger in vivo thyroid
imaging study by VA.
Materials and methods
Principles of VA
The VA technique is based on the radiation force of
ultrasound, which is a nonlinear phenomenon in acous-
tic wave propagation [33,34]. The general principle of
VA is illustrated in Figure 1.
VA uses two ultrasound beams at slightly different
frequencies (f1 and f2). The ultrasound energy is trans-
mitted in the form of two tonebursts. The beams are
oriented so that they intersect at their mutual focal
point. At this point, the two beams mix to produce an
ultrasound field with intensity that varies at the differ-
ence frequency, Δf, where, Δf = f2 − f1. The ultrasound
field produces a radiation force [33,34] on the object
at the focus of the combined beams. This force is pro-
portional to the intensity of the ultrasound field;
hence, it varies in time at the Δf. As a result, a sound
field at the Δf is produced and is detected by the
hydrophone. The hydrophone signal represents the ob-
ject’s dynamic response to the force exerted at one
point in the object. The hydrophone signal is used to
modulate the brightness of a point on the display that
corresponds to the position of the focal point on the
object. As the ultrasound beams are scanned across
the object, the VA image of the object is constructed
on the display. Although the image is constructed
from a low-frequency signal at Δf, which is often in
the kilohertz range, the spatial resolution of the image
is determined by the focal spot size, which is typically
in submillimeter to millimeter range—a range very
suitable for clinical imaging. Figure 1 demonstrates a
diagram of the experimental vibro-acoustography sys-
tem for thyroid imaging.
We note that VA images are in the C-plane, i.e., the
plane perpendicular to the ultrasound beam, which is
also perpendicular to the B-plane used in B-mode ultra-
sound imaging. This C-plane is a constant distance from
the surface of the transducer. Therefore, VA and B-mode
present two perpendicular cross-sections of tissue.
A VA image depicts two types of information about the
object. First, the image represents the ultrasonic proper-
ties of the object, such as its scattering and power
absorption characteristics. These properties are also
present in traditional ultrasonography [35]. The second
type of information is the dynamic characteristics of the
object at the Δf, which describes how the object responds
Figure 1 Diagram of the experimental vibro-acoustography system for in vitro thyroid imaging. The thyroid sample in the gel block is
placed inside a water tank and is then scanned by the dual-beam ultrasound from the confocal transducer focused at the desired depth inside
the sample. The difference frequency (Δ f) between the two ultrasound beams (f2 and f1) is represented as Δ f = f2- f1. The hydrophone receives
the acoustic field at the Δ f from the sample. This signal is then processed and mapped into an image.
Figure 2 Experimental setup for in vitro thyroid imaging by
vibro-acoustography. The excised thyroid is embedded in a
gel block.
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tion is not available from conventional ultrasound im-
aging. Because VA images are formed using the acoustic
signal at a low frequency, the resulting images are speckle
free, which is an important advantage over traditional
ultrasound imaging [36].
VA has been tested in numerous potential clinical ap-
plications, including in vitro experiments on heart valves
[37], in vitro human vessels [38], in vivo animal arteries
[39], breast tissue [40,41], liver tissue [42], bone [43],
and, more recently, in vivo human breast [44-46]. Recent
reports on prostate applications of VA include evaluation
of VA for imaging prostate brachytherapy seeds [47] and
for monitoring prostate cryotherapy [48]. It should be
noted that VA in its present form is not intended for
quantitative imaging. Diagnostic information from VA is
based on image contrast, which is also the case in most
other imaging modalities.
Imaging in vitro thyroid tissues
In an in vitro study, after obtaining the approval of the
Mayo Clinic Institutional Review Board (IRB) for tissue
specimens, experiments were conducted on a number of
whole excised human thyroids from autopsy. The speci-
mens were randomly taken and there was no previous
knowledge of the presence of nodules inside these thy-
roid tissues. Tissue samples were fixed in 10% formalde-
hyde for 1 hour to prevent potential contamination,
after which they were thoroughly rinsed in water to re-
move residual formaldehyde before embedding [42]. Tis-
sues were embedded in a tissue mimicking gel block
(~10 x 10 x 3 cm). To make the gel block, gelatin pow-
der (G2500, Sigma-Aldrich, St. Louis, MO) was first
dissolved in water in a 60 g/L ratio and heated to 50°C.
Once the gelatin was fully dissolved, glycerol (G7757,
Sigma-Aldrich, St. Louis, MO) was added at 10% by vol-
ume. The solution was then cooled to 42°C and the tissuespecimen was placed in the liquid gel. The tissue and li-
quid were degassed under vacuum to remove air from
both the tissue and liquid. After degassing, the liquid and
tissue specimen were carefully poured into a square mold
and refrigerated overnight before scanning.
The VA experiment was conducted in a water tank;
the diagram of the experimental VA for in vitro im-
aging is shown in Figure 1, where the tissue is scanned
by a dual-beam confocal ultrasound transducer focused
at the desired depth inside the sample. VA images were
acquired from each specimen. VA images, 50 × 50 mm,
were acquired at several Δf frequencies normally ran-
ging over 30–90 kHz. In addition to performing VA
with tonebursts of length 100 μs, we also used two
intersecting continuous wave (CW) focused ultrasound
beams of different frequencies to generate a localized os-
cillatory stress field for imaging. Figure 2 shows a photo-
graph of an excised thyroid embedded in a gel block
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imens were also imaged with a high-resolution specimen
radiography machine (M50; Faxitron, Wheeling, IL), ded-
icated for research.
Imaging human thyroid in vivo
After obtaining IRB approval, we recruited 24 (10 male
and 14 female) patient volunteers, who were being evalu-
ated for thyroid nodularity and were referred to the De-
partment of Radiology for FNAB. Ages of the subjects
ranged from 37 to 82 years old with a mean of 57.8 years
old. Normally, these patients have already undergone
diagnostic ultrasound examinations. Because the biopsy
needle may alter tissue characteristics, VA was performed
before FNAB to avoid these possible errors. B-mode
ultrasound and VA images of thyroid were obtained from
20 patients. The patient had his/her clinical FNAB after
this step as part of his or her health care. The nodule
or nodules selected for FNAs were marked as a region
of interest on thyroid ultrasound by our radiologist
(C.C.R.), which later was used for VA nodule detec-
tion. The results of biopsy were analyzed and evalu-
ated by a pathologist.
The diagram of the dual modality system for in vivo VA
and B-mode imaging is shown in Figure 3. For B/C-mode
and VA imaging we used a modified General ElectricFigure 3 Diagram of the dual modality system for in vivo VA and B-m
The computer-controlled probe slider translates the probe across the regio
the probe slides across the thyroid. The same sliding motion is used to acq
from the B-mode data at a depth that corresponds to the VA image planeultrasound scanner (Vivid 7, GE Healthcare Ultrasound
Cardiology, Horton, Norway), which was described by
Urban, et al. [49] A linear array transducer (7 L, GE
Healthcare Ultrasound Cardiology, Horton, Norway) was
used to scan the thyroid.
The transducer was mounted on a linear translation
stage that was controlled by an external PC. The trans-
ducer moved in the elevation direction of the transducer
to acquire B-mode images at consecutive parallel
planes; also the same mechanism is used to acquire VA
data from consecutive parallel lines of the VA image.
The C-mode images are formed by summing the
backscattered ultrasound signal from the B-mode images
using a window that was centered at a specified depth
and had a length of 2.5 mm.
For VA, the scanner produced two ultrasound beams
with different frequencies both focused at a joint focal
point. Electronic focusing delays are used to focus at dif-
ferent focal depths. The two beams were electronically
steered together across the object along the length of the
array (also called azimuthal direction). Comparing to the
system used for in vitro experiments, the steering func-
tion of the array probe along the azimuthal direction re-
places the similar scanning motion that was performed
for the in vitro VA imaging by mechanical means. The
ultrasound frequencies were around 3 MHz and Δf wasode imaging. The system can produce both B-mode and VA images.
n of interest (thyroid). A collection of B-mode images is recorded as
uire a VA image of the same region. The C-mode image is extracted
.
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had frequencies f1 = 3.64 MHz and f2 = 3.58 MHz mak-
ing Δf = 54 kHz. The beams were constructed using an
aperture with 64 elements which were assigned a signal
with frequency f1 adjacent to a group of 64 elements,
which were assigned a signal with frequency f2. This
aperture was translated across the transducer array as
described by Urban, et al. [49].
The hydrophone was placed on the neck of the subject
and the acoustic emission signal was recorded during
the VA scanning procedure. Multiple planes in depth
were investigated during each scanning session. All the
VA images were 50 × 47 mm.
Results
In vitro study results
To optimize the VA system for in vivo human studies, we
initially tested the system on 20 excised human whole
thyroid tissues. Vibro-acoustography images of excised
thyroids displayed calcifications and nodules. Thyroid
nodules and cysts were detectable. Image contrast was
significantly higher than ultrasound images. The VA ap-
pearance of a normal excised human thyroid tissue with
no nodules is seen in Figure 4. In Figure 5, a large calcifi-
cation, about 2.5 mm in diameter, is seen in VA and US
images of an excised human thyroid from a cadaver.
X-ray, C-mode US and VA images of an excised thyroid
tissue are shown in Figure 6. Three lesions, one of which
is calcified, are seen in all VA images. In the X-ray image
only the calcified lesion is seen, but the other two are not
visible. In the C-mode ultrasound image (tissue was cut
in 2 pieces) the nodules can be seen. In general, image
contrast in the VA images was substantially higher than
that in the ultrasound images in VA tissue experiments.Figure 4 VA image of an excised human healthy thyroid tissue.
The image size is 55 × 75 mm. The image is taken at 6 mm depth
and shows normal thyroid tissue structure with no nodule
and calcifications.In the in vitro study, we assessed the appearance of calci-
fications (CAs) and nodules in vibro-acoustography by
classifying each image into one of these three categories:
(A) Positive (clearly identified calcifications at locations
indicated in the corresponding X-ray image or nodules at
the locations indicated in the corresponding C-mode
US); (B) Suspicious (image showed some indication of
calcifications that could not be clearly differentiated from
the background tissue and in case of nodules the border
was not clearly defined); and (C) Negative (no calcifica-
tion could be distinguished at locations indicated in the
corresponding X-ray image and no nodules could be
distinguished at locations indicated in the correspond-
ing C-mode US image).
VA was able to detect all (3/3) of X-ray proven calcifi-
cations and all (2/2) of ultrasound proven nodules
within thyroid tissues (Table 1). The measurements of
the top right calcified nodule were 8.8 mm × 7.9 mm in
X-ray; 7.9 mm × 7.2 mm in C-mode; and 10.3 mm ×
8.7 mm in VA images. Since the goal of this in vitro
study was to optimize the system for our in vivo im-
aging, tissue samples were randomly chosen from hu-
man cadavers regardless of pathology.
In vivo study results
We performed thyroid VA and US imaging on 24 adult
patients on one side and on two lobes in one patient. All
the VA scans were 50 × 47 mm. The results from six pa-
tients are shown in Figures 7, 8, 9, 10, 11, 12.
Ultrasound data are depicted in B-mode and C-mode.
C-mode image plane corresponds to VA image plane,
where this plane is perpendicular to the B-mode image
plane. To clarify image orientation, we use a three-axis
Cartesian coordinate system of x, y, and z, where x repre-
sents the scan direction in B-mode image (also known as
azimuth direction), y represents the probe motion (also
known as elevation direction), and z representing the
depth. Ultrasound B-mode images are presented in the x-z
plane, while C-mode and VA images are in the x-y plane.
Figure 7 demonstrates US and VA images of the left
thyroid lobe of a 48-year-old female patient with a be-
nign thyroid nodule. B-mode ultrasound identifies a
large nodule measuring about 47 × 27 mm (x-z dimen-
sions) with small cystic appearance. The nodule appears
on C-mode US, taken at 2 cm depth, measuring about
44.2 mm × 30.5 mm (x-y dimensions). The VA image
taken at 2.0 cm depth identifies the large nodule with
distinct margin measuring about 30.5 mm in the y-direc-
tion and more than 47 mm in the x-direction, with its
side margins extending out of VA image window. Its
shape and location correlates to the US C-scan at 2 cm
depth. Note that the resolution cell of the VA system in
the depth direction was around 2–3 mm, which is simi-
lar to that of C-mode images.
Figure 5 Excised Human Thyroid. A) C-mode ultrasound of an excised human thyroid from a cadaver, B) VA image of this tissue in 60 × 60 mm
scan dimension. The arrow shows a 2.5 x 2.5 mm calcification in VA image with more contrast than shown in the US image.
Figure 6 Excised Human Thyroid. A) X-ray of an excised thyroid tissue from cadaver; B) US C-scan of the same tissue at 5 MHz; C) VA image
using toneburst excitation with Δf = 50 kHz. The image is 50 × 50 mm. D) VA image using CW excitation with Δf = 16.3 kHz. VA images were
taken in water tank. All VA images are 50 × 50 mm.
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Table 1 Summary of VA experimental results on 20 ex vivo
thyroid samples
Positive Suspicious Negative
Presence of X-ray proven calcification
in VA
3/3 0 0
Presence of ultrasound proven Nodules
in VA
2/2 0 0
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old man with a nodule on the left side of his thyroid.
The nodule on B-mode US measures about 29 × 42 ×
40 mm. On the VA scan at 1.75 cm depth, the nodule
appears larger and almost covers most of the scan image
with little normal tissue around, as denoted by arrows. It
should be noted that the VA scan depth was set to be
where the largest dimension of the nodule was observed
in the B-mode US image. The histology of the nodule re-
vealed benign appearance with degenerative changes.
Figure 9 demonstrates US and VA images of the left
side of the thyroid of a 56 year old female with a benign
adenoma. The nodule appears on B-mode and C-mode
US, taken at a depth of 1.25 cm, as an isoechoic nodule
protruding from the lower pole of the left thyroid lobe
measuring 12.5 mm × 12.0 mm in C-mode. The VA scan
at 2.25 cm depth identifies the nodule at the same loca-
tion seen in C-mode US but larger, measuring about
11.6 × 23.8 mm.
Figure 10 demonstrates US and VA images of the right
side thyroid of 37 year old male with papillary thyroid car-
cinoma. On B-mode US, a cystic nodule appears measur-
ing about l.0 × l.3 × l.4 cm in the upper right lobe of the
thyroid with peripheral calcifications, characteristic of aFigure 7 Benign Thyroid Nodule. A) B-mode US of a patient’s thyroid sh
on left lobe with a small cystic component, B) Ultrasound C-scan at 2.0 cm
and C) In vivo VA image of thyroid (with 7 L array probe, f1 = 3.64 MHz and
plane, measuring more than 47 mm in the x-direction and 30.5 mm in the
47 ×50 mm.papillary carcinoma. The VA scan at 2.5 cm depth identi-
fies the nodule with a cystic appearance and slightly larger
dimensions plus some peripheral calcifications, denoted by
arrows, with greater clarity than shown in the US image. It
is difficult to measure the size of the nodule in both the US
and VA images reliably due to indistinct margins.
Figure 11 presents US and VA images of a 41-year-old
woman with a thyroid nodule in the left lobe. On B-mode
US, two nodules appear, a cystic nodule measuring 2.6 ×
2.9 × 3.7 cm and an almost solid nodule about 2.1 cm in
greatest dimension with the coarse calcifications in the in-
ferior left lobe. The VA scan with the array probe at 2 cm
depth identifies the ill-defined nodules denoted by the cir-
cle. The VA scan is taken at the largest dimension of nod-
ule of its B-mode image. For this reason, the nodule
appears larger and covered most of the image. Coarse cal-
cifications appear on the VA image with greater clarity as
shown by arrows. The VA and US appearance were sug-
gestive for malignancy and the pathology of FNA sample
from the inferior left thyroid nodule containing coarse cal-
cifications revealed papillary thyroid carcinoma.
Figure 12 demonstrates US and VA images of the left
side thyroid of an 82-year-old male patient with benign
thyroid nodule with degenerative changes. In the inferior
aspect of the left thyroid lobe there is an oval well de-
fined heterogeneously echogenic nodule that measures
2.0 × 1.5 × 1.5 cm on B-mode ultrasound. The VA scan
at 2.0 cm depth identifies the nodule slightly larger, as
denoted by circle.
To assess the appearance of clinical ultrasound proven
nodules and CAs in B-mode and or C- mode, we classi-
fied each B/ C-mode image into one of the followingows a large solid nodule measuring 47×27 mm in the x-z dimensions
depth measuring about 44.2 mm x 30.5 mm in the x-y dimensions,
Δf = 54.27 kHz) at 2.0 cm depth which correlates to the one of C-scan
y-direction and the star shows the dimensions. The VA image is
Figure 8 Benign Thyroid Nodule with Degenerative Changes. A) B-mode US of 71 year old patient’s thyroid on left side. The arrow points to
a nodule measuring 2.9 × 4.2 × 4.0 cm, B) VA image at 2.25 cm depth, the arrows point a large nodule covering most of image. The pathology
result was a benign nodule with degenerative changes. The VA image is 47 × 50 mm. Orientations of the images are similar to those as Figure 7.
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seen at locations indicated in the corresponding clinical
US, B) Fair (image showed some indication of calcifica-
tions that could not be clearly differentiated from the
background tissue and in case of nodules part of the
border could not be identified. C) Inconclusive (no cal-
cification and nodules could be distinguished at loca-
tions indicated in the corresponding clinical US). The
same classification criteria were used for presence of
CAs and nodules in VA images were compared to the
corresponding B/C mode US.Figure 9 Benign Thyroid Nodule. A) B-mode US of left side of patient’s t
protruding from the lower pole of the left thyroid lobe, B) C-mode US at 2
nodule at the same location as seen in C-mode but larger, measuring abou
Figure 7.In summary, as shown in Table 2, VA was able to de-
tect 20 nodules out of 22 nodules that were detected in
the corresponding B/C-mode images, where 12 images
were classified as Good and 8 were classified as Fair, be-
cause VA images were affected by some types of artifacts
but the lesion was still detectable. In 2 cases the VA
image was classified as inconclusive.
VA was able to detect the US-detected calcifications
(CAs) with greater clarity though they appeared larger
than in US. In a number of experiments, some levels of
either system artifact or body motion artifact, mainlyhyroid identifies a nodule measuring 1.4 × 1.4 cm isoechoic nodule
.25 cm depth shows the nodule, C) VA scan at 2.25 cm depth shows
t 1.0 × 1.5 × 3.4 cm. Orientations of the images are similar to those as
Figure 10 Papillary Thyroid Cancer. A) B-mode US shows a cystic nodule measuring l.0 × l.3 × l.4 cm in the upper right lobe of the thyroid
with peripheral calcifications as denoted by arrows. VA scan at 2.5 cm depth shows the nodule with cystic appearance slightly larger dimensions
plus some coarse peripheral calcifications. Orientations of the images are similar to those as Figure 7.
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were dominant and masked the nodules. The pathology
revealed papillary thyroid carcinoma in two cases of VA-
detected nodules and the rest were benign. The two pap-
illary carcinomas had pathology-proven calcifications
that could be seen in US as well as VA images.
Discussion
In the in vitro study, the VA images could visualize normal
tissue structures and lesions free of the speckle associated
with conventional B-mode ultrasound as demonstrated inFigure 11 Papillary Thyroid Cancer. A) B-mode US shows a cystic nodul
2.1 cm in greatest dimension with peripheral coarse calcifications in the inf
ill-defined nodules, and partial cystic appearance. The VA scan is taken at t
covering most of the image, (shown by circle) with arrows pointing to the
Figure 7.Figures 4, 5 and 6. Figure 6 demonstrates that the X-ray
was only sensitive to one of the lesions that were present
and US revealed two nodules with no apparent calcifica-
tions, whereas the VA images could detect all three nod-
ules and calcifications in the thyroid tissue. Additionally,
the contrast and the edge detail were enhanced in the
VA images as compared to the US images. It should be
noted that, VA in the present form is not intended as a
quantitative imaging. Similar to most other medical im-
aging modalities, diagnostic information in VA is based
on image contrast.e measuring 2.6 cm × 2.9 cm × 3.7 cm and a solid nodule about
erior left lobe. B) VA scan with array probe at 2.0 cm depth shows the
he largest diameter of nodule of shown at B-mode and appears larger
calcifications. Orientations of the images are similar to those as
Figure 12 Benign Thyroid Nodule with Degenerative Changes. (A) B-mode US of left lobe of a patient’s thyroid, circle points to an oval
nodule measures 2.0 cm × 1.5 cm × 1.5 cm and (B) VA image at 2 cm depth (with 7 L array probe, f1 = 3.64 MHz and Δf = 54.27 kHz ) show a
large nodule in a human thyroid marked by circle. The vertical bands marked by the arrows are system artifacts. The pathology analysis revealed
that this was a benign nodule. Orientations of the images are similar to those as Figure 7.
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cantly change tissue properties; particularly it increases
tissue stiffness. However, we also note that the study on
excised tissue will have the benefit of providing valuable
information and allowing us to optimize our system be-
fore moving to in vivo studies. Although short term fix-
ing with formaldehyde somewhat alters the stiffness of
the thyroid tissue, such changes affect both healthy and
diseased areas. Hence, tissue fixation should not have a
major effect on the capability of VA imaging to detect a
contrast between normal and diseased tissue [42].
The confocal transducer used in this study was mech-
anically scanned in a water tank for the in vitro portion
of this study. With this experimental setup the scan time
could take 6–8 minutes. In order to translate this
method for clinical use and improve the scan times, the
modified scanner equipped with the linear array was
used for the in vivo study. This system acquires imagesTable 2 Results summary of 24 in vivo thyroid VA
experiments
Detctable Inconclusive
Appearance of nodules by B-mode 22/24 2/24
Appearance of B-mode US proven nodules
in VA
20/22 2/22
Appearance of Calcifications on B-mode 2 4/6





Histology of 20 VA detected nodules 2 18of similar size in about 2 minutes. It should be noted
since the beamforming technique used for in vivo im-
aging is significantly different from that used for in vitro
imaging; the resulting image quality is not the same.
One reason for such difference is the fact that the con-
focal transducer used in the in vitro experiments has a
large circular aperture that is capable of producing high-
resolution images with symmetric resolution cells. Such
images are typically smooth and clear. The beamforming
with linear array used for the in vivo study has a much
smaller aperture thus resulting in lower resolution images
and non-symmetric resolution cell. This is a limitation
of the ultrasound scanner – not the VA technique –
because the ultrasound scanner can only support linear
(rectangular) arrays with relatively small apertures.
The results from the in vivo study show that nodules
could be detected by in the VA images and the edges
could be defined. Size of nodules appeared larger in
most of VA images than in the corresponding B-mode
and C-mode images. The difference may be attributed to
the fact that the information content of VA and B-mode
are different; that is, VA is sensitive to properties of tis-
sue at ultrasound as well as low (Δf ) frequencies,
whereas B-mode and C-mode images are sensitive only
to the ultrasound properties of tissue. VA was able to de-
tect all the calcifications, in the form of micro- and
coarse calcifications, within the nodules with greater
clarity than those of seen in US. The histology of nodules
proved the presence of calcifications including in two
papillary carcinomas. It is known that the presence of
calcification within solitary thyroid nodule is highly asso-
ciated with thyroid malignancy [50-54]. VA is sensitive to
Alizad et al. BMC Medical Imaging 2013, 13:12 Page 11 of 13
http://www.biomedcentral.com/1471-2342/13/12calcifications and to our experience [37,41,45,46], it
shows calcifications better than ultrasound. In US calcifi-
cations are often detected by their shadow, but in VA we
can directly see and identify calcifications.
There were a few difficulties that were encountered in
the in vivo study. First, we have identified a system
artifact associated with steering the VA beams across the
aperture which creates streaks in the resulting image.
These types of artifacts were observed in Figure 12B as
marked by arrows. We have developed an algorithm to
correct for these streaks [49], but this algorithm can, in
some instances, diminish image details and we are work-
ing on alternatives to correct this artifact.
Additionally, during the in vivo scanning, there is an
artifact associated with motion due to patient breathing.
This breathing artifact is manifested as jagged image de-
tails. A mild case of this artifact is shown in Figure 7C
with jagged edges in the horizontal direction when com-
paring adjacent vertical rows. When the patient breathes,
the thyroid can move in and out of the VA focal plane,
so the same tissue is not necessarily excited. Because the
scan takes about 2 minutes, we could not ask the subject
to simply hold their breath. We did ask the patient to
breath shallowly to avoid large excursions. We also
placed the transducer on a spring mounted assembly so
that the transducer would move with the patient during
breathing as well as conform to the neck of the subject.
Another limitation of this study is the limited sample
size. It should be noted that the goal of this paper is to
report the results of a pilot study conducted on a small
number of thyroids and provide the basis for future
studies. We did not intend or claim to have sufficient
number of samples for a complete statistical analysis.
For this reason we have not presented a sample size cal-
culation. Results of this study may be used to determine
the sample size for future studies. A larger study would
provide a more accurate assessment of the sensitivity and
specificity of thyroid nodule detection by VA. Results of
this paper suggest that VA may be used as an additional
thyroid imaging tool, however, this method is not meant
to replace B-mode US or FNAB at present time.
Conclusion
Herein, we have reported on our examination of the use
of VA for in vitro and in vivo imaging of the thyroid.
This study was a prerequisite for a larger population of
thyroid patients. Our experiments on excised and in vivo
thyroids demonstrate the capability of VA for the detec-
tion of thyroid nodules and calcifications. These results
suggest that VA may be a useful clinical tool in thyroid
imaging; however, at present VA is not intended to re-
place B-mode US or FNAB. In conclusion, our pilot
study has shown that thyroid vibro-acoustography is
feasible. However, larger studies are needed to determinesensitivity and specificity of this imaging tool in thyroid
cancer detection and differentiation.
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